KPC Pharmaceuticals, Inc

Kunming, Yunnan Sheng, China


Purpose

to achieve WHO prequalification of DHA-PQP as anti-malarial treatment

Division

Global Health, Global Policy and Advocacy

Date

October 2018

Region Served

AFRICA

Committed amount

$1,251,532

Grant topic

Global Health and Development Public Awareness and Analysis, Malaria

Duration (months)

54

Grantee location

Kunming, Yunnan Sheng, China

Related work

Malaria

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.